A Randomized, Controlled Study of Two Dosages of Dalfampridine on Walking in Stroke

To compare efficacy of dalfanpridine-extended release(DALF-ER) administered at 7.5mg or 10 mg with a placebo tablet on post-stroke ambulation.

Source: Archives of Physical Medicine and Rehabilitation - September 25, 2019 Category: Rehabilitation Authors: Stephen Page Source Type: research